Definitive Healthcare (NASDAQ:DH) Posts Earnings Results

by · The Markets Daily

Definitive Healthcare (NASDAQ:DH – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02, FiscalAI reports. Definitive Healthcare had a negative net margin of 69.18% and a positive return on equity of 4.07%. The company had revenue of $54.65 million for the quarter, compared to analyst estimates of $54.58 million.

Definitive Healthcare Stock Up 1.8%

Shares of DH stock traded up $0.02 during trading hours on Friday, reaching $1.15. The company had a trading volume of 324,402 shares, compared to its average volume of 394,086. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.86 and a current ratio of 1.86. Definitive Healthcare has a twelve month low of $0.61 and a twelve month high of $3.00. The company has a market capitalization of $122.76 million, a P/E ratio of -0.77, a price-to-earnings-growth ratio of 14.19 and a beta of 1.40. The stock’s fifty day simple moving average is $1.02 and its 200 day simple moving average is $1.06.

Wall Street Analyst Weigh In

DH has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $1.00 target price on shares of Definitive Healthcare in a report on Wednesday, August 12th. Wall Street Zen upgraded Definitive Healthcare from a “hold” rating to a “buy” rating in a research note on Sunday, September 13th. BTIG Research restated a “neutral” rating on shares of Definitive Healthcare in a research note on Friday, September 4th. Weiss Ratings upgraded Definitive Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday. Finally, Morgan Stanley reduced their price objective on Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. Six equities research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $1.47.

Get Our Latest Research Report on DH

About Definitive Healthcare

(Get Free Report)

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.

Read More